Literature DB >> 31161223

Traditional Cardiovascular Risk Factors and Individual Prediction of Cardiovascular Events in Childhood Cancer Survivors.

Yan Chen1, Eric J Chow2, Kevin C Oeffinger3, William L Border4, Wendy M Leisenring2, Lillian R Meacham4, Daniel A Mulrooney5, Charles A Sklar6, Marilyn Stovall7, Leslie L Robison5, Gregory T Armstrong5, Yutaka Yasui1,5.   

Abstract

BACKGROUND: Childhood cancer survivors have an increased risk of heart failure, ischemic heart disease, and stroke. They may benefit from prediction models that account for cardiotoxic cancer treatment exposures combined with information on traditional cardiovascular risk factors such as hypertension, dyslipidemia, and diabetes.
METHODS: Childhood Cancer Survivor Study participants (n = 22 643) were followed through age 50 years for incident heart failure, ischemic heart disease, and stroke. Siblings (n = 5056) served as a comparator. Participants were assessed longitudinally for hypertension, dyslipidemia, and diabetes based on self-reported prescription medication use. Half the cohort was used for discovery; the remainder for replication. Models for each outcome were created for survivors ages 20, 25, 30, and 35 years at the time of prediction (n = 12 models).
RESULTS: For discovery, risk scores based on demographic, cancer treatment, hypertension, dyslipidemia, and diabetes information achieved areas under the receiver operating characteristic curve and concordance statistics 0.70 or greater in 9 and 10 of the 12 models, respectively. For replication, achieved areas under the receiver operating characteristic curve and concordance statistics 0.70 or greater were observed in 7 and 9 of the models, respectively. Across outcomes, the most influential exposures were anthracycline chemotherapy, radiotherapy, diabetes, and hypertension. Survivors were then assigned to statistically distinct risk groups corresponding to cumulative incidences at age 50 years of each target outcome of less than 3% (moderate-risk) or approximately 10% or greater (high-risk). Cumulative incidence of all outcomes was 1% or less among siblings.
CONCLUSIONS: Traditional cardiovascular risk factors remain important for predicting risk of cardiovascular disease among adult-age survivors of childhood cancer. These prediction models provide a framework on which to base future surveillance strategies and interventions.
© The Author(s) 2019. Published by Oxford University Press. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Mesh:

Year:  2020        PMID: 31161223      PMCID: PMC7073918          DOI: 10.1093/jnci/djz108

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  39 in total

1.  Survival model predictive accuracy and ROC curves.

Authors:  Patrick J Heagerty; Yingye Zheng
Journal:  Biometrics       Date:  2005-03       Impact factor: 2.571

Review 2.  Pediatric cancer survivorship research: experience of the Childhood Cancer Survivor Study.

Authors:  Wendy M Leisenring; Ann C Mertens; Gregory T Armstrong; Marilyn A Stovall; Joseph P Neglia; Jennifer Q Lanctot; John D Boice; John A Whitton; Yutaka Yasui
Journal:  J Clin Oncol       Date:  2009-04-13       Impact factor: 44.544

Review 3.  Recommendations for cardiomyopathy surveillance for survivors of childhood cancer: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group.

Authors:  Saro H Armenian; Melissa M Hudson; Renee L Mulder; Ming Hui Chen; Louis S Constine; Mary Dwyer; Paul C Nathan; Wim J E Tissing; Sadhna Shankar; Elske Sieswerda; Rod Skinner; Julia Steinberger; Elvira C van Dalen; Helena van der Pal; W Hamish Wallace; Gill Levitt; Leontien C M Kremer
Journal:  Lancet Oncol       Date:  2015-03       Impact factor: 41.316

4.  Longitudinal data analysis for discrete and continuous outcomes.

Authors:  S L Zeger; K Y Liang
Journal:  Biometrics       Date:  1986-03       Impact factor: 2.571

5.  Modifiable risk factors and major cardiac events among adult survivors of childhood cancer.

Authors:  Gregory T Armstrong; Kevin C Oeffinger; Yan Chen; Toana Kawashima; Yutaka Yasui; Wendy Leisenring; Marilyn Stovall; Eric J Chow; Charles A Sklar; Daniel A Mulrooney; Ann C Mertens; William Border; Jean-Bernard Durand; Leslie L Robison; Lillian R Meacham
Journal:  J Clin Oncol       Date:  2013-09-03       Impact factor: 44.544

6.  Testing for improvement in prediction model performance.

Authors:  Margaret Sullivan Pepe; Kathleen F Kerr; Gary Longton; Zheyu Wang
Journal:  Stat Med       Date:  2013-01-07       Impact factor: 2.373

7.  Prediction of lifetime risk for cardiovascular disease by risk factor burden at 50 years of age.

Authors:  Donald M Lloyd-Jones; Eric P Leip; Martin G Larson; Ralph B D'Agostino; Alexa Beiser; Peter W F Wilson; Philip A Wolf; Daniel Levy
Journal:  Circulation       Date:  2006-02-06       Impact factor: 29.690

8.  Clinical ascertainment of health outcomes among adults treated for childhood cancer.

Authors:  Melissa M Hudson; Kirsten K Ness; James G Gurney; Daniel A Mulrooney; Wassim Chemaitilly; Kevin R Krull; Daniel M Green; Gregory T Armstrong; Kerri A Nottage; Kendra E Jones; Charles A Sklar; Deo Kumar Srivastava; Leslie L Robison
Journal:  JAMA       Date:  2013-06-12       Impact factor: 56.272

9.  Racial/Ethnic Differences in Adverse Outcomes Among Childhood Cancer Survivors: The Childhood Cancer Survivor Study.

Authors:  Qi Liu; Wendy M Leisenring; Kirsten K Ness; Leslie L Robison; Gregory T Armstrong; Yutaka Yasui; Smita Bhatia
Journal:  J Clin Oncol       Date:  2016-03-21       Impact factor: 44.544

Review 10.  Survivors of childhood and adolescent cancer: life-long risks and responsibilities.

Authors:  Leslie L Robison; Melissa M Hudson
Journal:  Nat Rev Cancer       Date:  2013-12-05       Impact factor: 60.716

View more
  19 in total

Review 1.  The Future of Childhood Cancer Survivorship: Challenges and Opportunities for Continued Progress.

Authors:  Stephanie B Dixon; Eric J Chow; Lars Hjorth; Melissa M Hudson; Leontien C M Kremer; Lindsay M Morton; Paul C Nathan; Kirsten K Ness; Kevin C Oeffinger; Gregory T Armstrong
Journal:  Pediatr Clin North Am       Date:  2020-12       Impact factor: 3.278

2.  Late health outcomes after dexrazoxane treatment: A report from the Children's Oncology Group.

Authors:  Eric J Chow; Richard Aplenc; Lynda M Vrooman; David R Doody; Yuan-Shung V Huang; Sanjeev Aggarwal; Saro H Armenian; K Scott Baker; Smita Bhatia; Louis S Constine; David R Freyer; Lisa M Kopp; Wendy M Leisenring; Barbara L Asselin; Cindy L Schwartz; Steven E Lipshultz
Journal:  Cancer       Date:  2021-10-13       Impact factor: 6.860

Review 3.  Hypertension in Cancer Survivors: A Review of the Literature and Suggested Approach to Diagnosis and Treatment.

Authors:  David Chuquin; Antonio Abbate; Wendy Bottinor
Journal:  J Cardiovasc Pharmacol       Date:  2022-10-01       Impact factor: 3.271

4.  Research Quality and Impact of Cardiac Rehabilitation in Cancer Survivors: A Systematic Review and Meta-Analysis.

Authors:  Reza Fakhraei; Serena S Peck BKin; Husam Abdel-Qadir; Paaladinesh Thavendiranathan; Catherine M Sabiston; Fernando Rivera-Theurel; Paul Oh; Ani Orchanian-Cheff; Leanna Lee; Scott C Adams
Journal:  JACC CardioOncol       Date:  2022-06-21

5.  Underdiagnosis and Undertreatment of Modifiable Cardiovascular Risk Factors Among Survivors of Childhood Cancer.

Authors:  Eric J Chow; Yan Chen; Gregory T Armstrong; Laura-Mae Baldwin; Casey R Cai; Todd M Gibson; Melissa M Hudson; Aaron McDonald; Paul C Nathan; Jeffrey E Olgin; Karen L Syrjala; Emily S Tonorezos; Kevin C Oeffinger; Yutaka Yasui
Journal:  J Am Heart Assoc       Date:  2022-06-08       Impact factor: 6.106

6.  Risk of Cardiometabolic Risk Factors in Women With and Without a History of Breast Cancer: The Pathways Heart Study.

Authors:  Marilyn L Kwan; Richard K Cheng; Carlos Iribarren; Romain Neugebauer; Jamal S Rana; Mai Nguyen-Huynh; Zaixing Shi; Cecile A Laurent; Valerie S Lee; Janise M Roh; Hanjie Shen; Eileen Rillamas-Sun; Margarita Santiago-Torres; Dawn L Hershman; Lawrence H Kushi; Heather Greenlee
Journal:  J Clin Oncol       Date:  2022-01-13       Impact factor: 50.717

7.  Cardiometabolic Risk in Childhood Cancer Survivors: A Report from the Children's Oncology Group.

Authors:  Emma R Lipshultz; Eric J Chow; David R Doody; Saro H Armenian; Barbara L Asselin; K Scott Baker; Smita Bhatia; Louis S Constine; David R Freyer; Lisa M Kopp; Cindy L Schwartz; Steven E Lipshultz; Lynda M Vrooman
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2022-03-01       Impact factor: 4.090

8.  Artificial Intelligence-Assisted Prediction of Late-Onset Cardiomyopathy Among Childhood Cancer Survivors.

Authors:  Fatma Güntürkün; Oguz Akbilgic; Robert L Davis; Gregory T Armstrong; Rebecca M Howell; John L Jefferies; Kirsten K Ness; Ibrahim Karabayir; John T Lucas; Deo Kumar Srivastava; Melissa M Hudson; Leslie L Robison; Elsayed Z Soliman; Daniel A Mulrooney
Journal:  JCO Clin Cancer Inform       Date:  2021-04

9.  Medical Financial Hardship in Survivors of Adolescent and Young Adult Cancer in the United States.

Authors:  Amy D Lu; Zhiyuan Zheng; Xuesong Han; Ruowen Qi; Jingxuan Zhao; K Robin Yabroff; Paul C Nathan
Journal:  J Natl Cancer Inst       Date:  2021-08-02       Impact factor: 11.816

Review 10.  Onco-Cardiology: Consensus Paper of the German Cardiac Society, the German Society for Pediatric Cardiology and Congenital Heart Defects and the German Society for Hematology and Medical Oncology.

Authors:  Tienush Rassaf; Matthias Totzeck; Johannes Backs; Carsten Bokemeyer; Michael Hallek; Denise Hilfiker-Kleiner; Andreas Hochhaus; Diana Lüftner; Oliver J Müller; Ulrich Neudorf; Roman Pfister; Stephan von Haehling; Lorenz H Lehmann; Johann Bauersachs
Journal:  Clin Res Cardiol       Date:  2020-05-13       Impact factor: 5.460

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.